Deep Venous Thrombosis

Also known as: Venous Thrombosis, Deep / DVT / Deep venous thrombosis NOS / DVT - not obstetric / Thrombosis venous deep / Deep vein thrombosis NOS / Deep vein thrombosis

DrugDrug NameDrug Description
DB06695Dabigatran etexilateDabigatran etexilate is an oral prodrug that is metabolized by a serum esterase to [dabigatran]. It is a synthetic, competitive and reversible direct thrombin inhibitor. Inhibition of thrombin disrupts the coagulation cascade and inhibits the formation of clots. Dabigatran etexilate may be used to decrease the risk of venous thromboembolic events in patients who have undergone total hip or knee replacement surgery, or to prevent stroke and systemic embolism in patients with atrial fibrillation, in whom anticoagulation therapy is indicated. In contrast to warfarin, because its anticoagulant effects are predictable, lab monitoring is not necessary. FDA approved on October 19, 2010.
DrugDrug NamePhaseStatusCount
DB01225Enoxaparin0Completed1
DB11728Fondaparinux0Completed1
DB00006Bivalirudin1Completed1
DB01225Enoxaparin1Completed1
DB01225Enoxaparin1 / 2Completed1
DB01225Enoxaparin2Completed1
DB01225Enoxaparin2Recruiting1
DB00945Acetylsalicylic acid2 / 3Unknown Status1
DB06605Apixaban2 / 3Recruiting1
DB11095Desirudin2 / 3Completed1
DB01109Heparin2 / 3Completed1
DB00682Warfarin2 / 3Recruiting1
DB06779Dalteparin3Completed1
DB01225Enoxaparin3Recruiting1
DB01109Heparin3Completed2
DB06406Idraparinux3Completed1
DB00946Phenprocoumon3Unknown Status1
DB06228Rivaroxaban3Recruiting1
DB06822Tinzaparin3Completed1
DB00316Acetaminophen4Completed1
DB06605Apixaban4Recruiting1
DB06779Dalteparin4Recruiting1
DB01225Enoxaparin4Recruiting1
DB01109Heparin4Recruiting1
DB08813Nadroparin4Recruiting1
DB06822Tinzaparin4Recruiting1
DB00682Warfarin4Completed1
DB08813NadroparinNot AvailableCompleted2
DB06228RivaroxabanNot AvailableRecruiting1
DB00682WarfarinNot AvailableRecruiting1
DB00682WarfarinNot AvailableUnknown Status1